Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors

Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors

US Patent 11130751 · Granted Sep 28, 2021

Estimated economic value: $293,549,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridine rings containing derivatives as MALT1 inhibitors2025
Process for preparing imidazole derivatives2025
Condensed bicyclic heterocyclic derivatives as pest control agents2025
Spirobicyclic analogues2024
Spiro bicyclic inhibitors of menin-MLL interaction2024
Spiro bicyclic inhibitors of menin-MLL interaction2024
Pyrazole derivatives as MALT1 inhibitors2024
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for us2024
Heterocycle derivatives as pesticides2024
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inh2024
Spirobicyclic analogues2023
Heterocycle derivatives as pesticides2023